RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | -88.4% | 18,270 | -77.5% | 0.00% | – |
| Q2 2022 | $69,000 | -92.1% | 81,055 | -48.6% | 0.00% | -100.0% |
| Q1 2022 | $869,000 | +186.8% | 157,786 | +403.9% | 0.01% | +133.3% |
| Q4 2021 | $303,000 | +98.0% | 31,315 | +264.8% | 0.00% | +50.0% |
| Q3 2021 | $153,000 | -54.7% | 8,585 | -38.0% | 0.00% | -50.0% |
| Q2 2021 | $338,000 | +64.9% | 13,842 | +78.7% | 0.00% | +33.3% |
| Q1 2021 | $205,000 | +21.3% | 7,748 | -56.4% | 0.00% | 0.0% |
| Q4 2019 | $169,000 | +56.5% | 17,789 | +29.3% | 0.00% | +50.0% |
| Q3 2019 | $108,000 | – | 13,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |